Group 1 - The core viewpoint of the article is that as of August 22, 2025, institutional investors hold a total of 529 million shares of Jinjia Co., accounting for 36.45% of the company's total share capital, with a slight decrease of 0.63 percentage points compared to the previous quarter [1] Group 2 - Six institutional investors have disclosed their holdings in Jinjia Co., including Shenzhen Jinjia Venture Capital Co., Xinjiang Century Yuntong Equity Investment Partnership, Hong Kong Central Clearing Limited, Fujian Lexiang Investment Co., Morgan Stanley & Co. International PLC, and Hongde Yuexiang One-Year Holding Period Mixed A [1] - One new public fund has been disclosed this period, which is Hongde Yuexiang One-Year Holding Period Mixed A, while two public funds, Southern CSI 1000 ETF and Huaxia CSI 1000 ETF, were not disclosed in this period [1] - One social security fund, the National Social Security Fund 503 Portfolio, was not disclosed in this period compared to the previous quarter [1] - Foreign investment sentiment shows an increase in holdings from one foreign fund, Hong Kong Central Clearing Limited, with an increase of 0.48% [1]

Core Viewpoint - Fengyuan Pharmaceutical (000153.SZ) released its semi-annual report for 2025, indicating a total institutional holding of 141 million shares, accounting for 30.39% of the company's total equity, with a slight decrease of 0.36 percentage points from the previous quarter [1] Institutional Holdings - As of August 21, 2025, seven institutional investors disclosed their holdings in Fengyuan Pharmaceutical, with a combined shareholding of 141 million shares [1] - The institutional investors include Anhui Wuwei Pharmaceutical Factory, Bengbu Tushan Enterprise Management Co., Ltd., Ma'anshan Fengyuan Enterprise Management Co., Ltd., Anhui Fengyuan Group Co., Ltd., Great Wall Guorong Investment Management Co., Ltd., BARCLAYS BANK PLC, and Guojin 300 Index Enhanced A [1] - The total institutional holding percentage decreased by 0.36 percentage points compared to the previous quarter [1] Public Fund and Foreign Investment - One new public fund disclosed its holdings this period, namely Guojin 300 Index Enhanced A [1] - Two public funds that were previously disclosed did not report this quarter, including Guojin CSI A500 Index Enhanced A and Dongxing Lianzhong One-Year Holding Period Mixed A [1] - One new foreign institution disclosed its holdings, BARCLAYS BANK PLC, while MORGAN STANLEY & CO. INTERNATIONAL PLC was not reported this quarter [1]

2025年8月22日，国际医学(000516.SZ)发布2025年半年度报告。截至2025年8月21日，共有6个机构投资 者披露持有国际医学A股股份，合计持股量达7.42亿股，占国际医学总股本的33.14%。其中，机构投资 者包括陕西世纪新元商业管理有限公司、申华控股集团有限公司、银河德睿资本管理有限公司、西安商 业科技开发公司、申万宏源证券有限公司、香港中央结算有限公司，机构投资者合计持股比例达 33.14%。相较于上一季度，机构持股比例合计下跌了0.46个百分点。 公募基金方面，本期较上一季未再披露的公募基金共计4个，包括汇添富医疗积极成长一年持有混合 A、金鹰策略配置混合、广发资管盛世精选混合A、浙商汇金转型驱动。 外资态度来看，本期较上一季度持股减少的外资基金共计1个，即香港中央结算有限公司，持股减少占 比达0.29%。 以上内容与数据，与有连云立场无关，不构成投资建议。据此操作，风险自担。 ...

Group 1 - The core viewpoint of the news is that Tongchen Beijian (300146.SZ) reported its semi-annual results for 2025, revealing a total of 1.07 billion shares held by institutional investors, accounting for 6.27% of the company's total equity [1] - As of August 8, 2025, there are 9 institutional investors holding shares in Tongchen Beijian, with a slight decrease of 0.09 percentage points in institutional holding compared to the previous quarter [1] - The institutional investors include various funds such as E Fund's ChiNext ETF and Hong Kong Central Clearing Limited, indicating a diverse investment base [1] Group 2 - In the public fund sector, 4 funds increased their holdings, with a total increase of 0.12% compared to the previous period [2] - One public fund, E Fund's ChiNext ETF, reported a slight decrease in holdings, while one fund, Huatai-PineBridge's major consumption ETF, did not disclose holdings this period [2] - Foreign investment sentiment showed a decrease in holdings from Hong Kong Central Clearing Limited, with a reduction of 0.13% compared to the previous quarter [2]

公募基金方面本期较上一季度持股减少的公募基金共计1个，即南方中证全指房地产ETF，持股减少占 比达0.27%。本期较上一季度新披露的公募基金共计17个，主要包括中证2000、华夏中证全指房地产 ETF、国泰国证房地产行业指数A、鹏华国证2000指数增强A、广发成长优选混合等。本期较上一季未 再披露的公募基金共计3个，包括华宝量化选股混合发起式A、华宝中证500增强A、广发量化多因子混 合。 2025年4月19日，中国武夷(000797.SZ)发布2024年年度报告。截至2025年4月18日，共有22个机构投资 者披露持有中国武夷A股股份，合计持股量达8.93亿股，占中国武夷总股本的56.86%。其中，前十大机 构投资者包括福建建工集团有限责任公司、福建省能源集团有限责任公司、国信证券股份有限公司、香 港中央结算有限公司、中国工商银行股份有限公司-南方中证全指房地产交易型开放式指数证券投资基 金、中证2000、华夏中证全指房地产ETF、国泰国证房地产行业指数A、鹏华国证2000指数增强A、广 发成长优选混合，前十大机构投资者合计持股比例达56.83%。相较于上一季度，前十大机构持股比例 合计下跌了0.60个百分 ...